The life science industry is projected to maintain a high growth rate due to the rapid graying of society. By 2018, people aged 65 and over is expected to represent 10% of the world population, with Japan, Western Europe and China representing 25%, 20% and 10%, respectively of each country’s population.

Above all, drugs and medical devices sectors are experiencing significant changes due to innovation in technology and containment of medical costs. On the other hand, global activity in the life science sector including biotechnology used in medical care, environmental conservation, agriculture, timber and fisheries, and chemical industries, has been transitioning towards large scale research and development as well as funding.

In addition to providing accounting audit and financial advisory services, we at BDO will provide a wide range of services according to client needs including professional consulting by leveraging our group's extensive knowledge and expertise in life sciences.